Irinotecan (often combined as FOLFIRI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irinotecan (often combined as FOLFIRI), covering 2019-12-26 to 2019-12-26. Get the full timeline:
Most recent: Clinical Trial Update: Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer [Phase 2]